ELOVL6 (ELOVL fatty acid elongase 6)

2003-05-01  

Identity

HGNC
LOCATION
4q25
LOCUSID
ALIAS
FACE,FAE,LCE
FUSION GENES

Other Information

Locus ID:

NCBI: 79071
MIM: 611546
HGNC: 15829
Ensembl: ENSG00000170522

Variants:

dbSNP: 79071
ClinVar: 79071
TCGA: ENSG00000170522
COSMIC: ELOVL6

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000170522ENST00000302274Q9H5J4
ENSG00000170522ENST00000302274A0A024RDK5
ENSG00000170522ENST00000394607Q9H5J4
ENSG00000170522ENST00000394607A0A024RDK5
ENSG00000170522ENST00000503885D6RHI2
ENSG00000170522ENST00000506625D6RCU0
ENSG00000170522ENST00000514184D6RBP4

Expression (GTEx)

0
5
10
15
20

Pathways

PathwaySourceExternal ID
Fatty acid elongationKEGGko00062
Biosynthesis of unsaturated fatty acidsKEGGko01040
Fatty acid elongationKEGGhsa00062
Biosynthesis of unsaturated fatty acidsKEGGhsa01040
Fatty acid biosynthesis, elongation, endoplasmic reticulumKEGGhsa_M00415
Fatty acid biosynthesis, elongation, endoplasmic reticulumKEGGM00415
Fatty acid metabolismKEGGhsa01212
Fatty acid metabolismKEGGko01212
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Fatty acid, triacylglycerol, and ketone body metabolismREACTOMER-HSA-535734
Triglyceride BiosynthesisREACTOMER-HSA-75109
Fatty Acyl-CoA BiosynthesisREACTOMER-HSA-75105
Synthesis of very long-chain fatty acyl-CoAsREACTOMER-HSA-75876
Regulation of cholesterol biosynthesis by SREBP (SREBF)REACTOMER-HSA-1655829
Activation of gene expression by SREBF (SREBP)REACTOMER-HSA-2426168

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
376821722023ELOVL6 is associated with immunosuppression in lung adenocarcinoma through bioinformatics analysis.0
376821722023ELOVL6 is associated with immunosuppression in lung adenocarcinoma through bioinformatics analysis.0
319562342019FADS2 and ELOVL6 mutation frequencies in Japanese Crohn's disease patients.3
319562342019FADS2 and ELOVL6 mutation frequencies in Japanese Crohn's disease patients.3
297003192018Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression.27
297003192018Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression.27
268628482016Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.30
277936732016Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay.1
268628482016Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.30
277936732016Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay.1
257941622015The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients.6
257941622015The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients.6
247140862014Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.26
250039942014Two modes of regulation of the fatty acid elongase ELOVL6 by the 3-ketoacyl-CoA reductase KAR in the fatty acid elongation cycle.12
247140862014Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.26

Citation

Dessen P

ELOVL6 (ELOVL fatty acid elongase 6)

Atlas Genet Cytogenet Oncol Haematol. 2003-05-01

Online version: http://atlasgeneticsoncology.org/gene/40446/favicon/css/js/lib/jquery-3.5.1.min.js